Trial Information

Summary: Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).

In this clinical study we are seeking volunteers to test the effectiveness of the study drug for the treatment of children with moderate to severely active ulcerative colitis (UC).

The study drug has already been approved in the US for the treatment of UC in adults, and was approved in 2006 for the treatment of Crohn’s Disease in pediatric patients.

Study inclusion / exclusion criteria:

• 6-17 years of age
• Have moderately to severely active UC
• Have UC for at least 2 weeks
• Have not received infliximab or any other TNF antagonist

* not a full list of criteria

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 11, 2008 at 2:34:45 PM